default author photo

Lida A. Mina

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

107

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Retrospective Analysis of Osteonecrosis of the Jaw in Breast Cancer Patients Receiving Bone Modifying Agents for Bone Metastases

Number of pages: 18 Posted: 03 Jan 2025
Taylor Praska, Cassia Griswold, Melissa Noyes, Lida A. Mina, Alyssa McGary, Cammy Yu and Farah Raheem
Banner MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 57 (1,000,027)

Abstract:

Loading...

osteonecrosis, zoledronic acid, denosumab

2.

Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with Parp Inhibitors: The Mayo Clinic Experience

Number of pages: 26 Posted: 18 Jul 2024
Nusrat Jahan, Jodi Taraba, Nicholas J. Boddicker, Karthik V. Giridhar, Roberto A. Leon-Ferre, Amye J. Tevaarwerk, Elizabeth Cathcart-Rake, Ciara C. O'Sullivan, Prema P. Peethambaram, Timothy J. Hobday, Lida A. Mina, Felipe Batalini, Pooja Advani, Kostandinos Sideras, Tufia C. Haddad, Kathryn J. Ruddy, Matthew P. Goetz, Fergus Couch and Siddhartha Yadav
University of Alabama at Birmingham, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, affiliation not provided to SSRN, Mayo Clinic, affiliation not provided to SSRN, affiliation not provided to SSRN, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic - Department of Pathology and Mayo Clinic - Mayo Clinic Hospital
Downloads 50 (1,086,013)

Abstract:

Loading...

breast cancer, metastatic, PARP inhibitor, olaparib, talazoparib, and real-world